These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 5098670)

  • 41. Antibody response to the influenza vaccine in healthcare workers.
    Sacadura-Leite E; Sousa-Uva A; Rebelo-de-Andrade H
    Vaccine; 2012 Jan; 30(2):436-41. PubMed ID: 22064268
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Influenza immunization. A new vaccine.
    Cromwell HA; Brandon FB; McLean IW; Sadusk JF
    JAMA; 1969 Nov; 210(8):1438-42. PubMed ID: 5394875
    [No Abstract]   [Full Text] [Related]  

  • 43. Immunization of children with chronic lung disease with inactivated bivalent influenza vaccine.
    Jamison RM; Hilman BC; Kelly DA
    South Med J; 1972 Jul; 65(7):823-9. PubMed ID: 5038174
    [No Abstract]   [Full Text] [Related]  

  • 44. Immunogenicity and protective efficacy of influenza vaccination.
    Hannoun C; Megas F; Piercy J
    Virus Res; 2004 Jul; 103(1-2):133-8. PubMed ID: 15163501
    [No Abstract]   [Full Text] [Related]  

  • 45. Anti-neuraminidase antibody response in serum and nasal secretions following intranasal or subcutaneous inactivated A2-Hong Kong-68 influenza virus vaccine.
    Fedson DS; Fulk RV; Huber MA; Reisberg MA; Kasel JA
    J Immunol; 1971 Sep; 107(3):730-7. PubMed ID: 4999093
    [No Abstract]   [Full Text] [Related]  

  • 46. Antineuraminidase antibody response of man to influenza virus neuraminidase N2: results obtained with an improved hemagglutination inhibition technique and an enzyme inhibition test.
    Hennessy AV; Minuse E; Davenport FM
    J Immunol; 1972 Aug; 109(2):213-6. PubMed ID: 5047368
    [No Abstract]   [Full Text] [Related]  

  • 47. An assessment of oil adjuvant and aqueous influenza vaccines. II. Antibody responses to the vaccines.
    Forsyth JR; Russell EE
    J Hyg (Lond); 1967 Dec; 65(4):497-504. PubMed ID: 5235255
    [No Abstract]   [Full Text] [Related]  

  • 48. Active influenza immunization in hemodialysis patients: comparison between single-dose and booster vaccination.
    Song JY; Cheong HJ; Ha SH; Kee SY; Jeong HW; Kim WJ
    Am J Nephrol; 2006; 26(2):206-11. PubMed ID: 16699258
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Balanced and normative view on preventive influenza vaccination in the GFR (German Federal Republic) on an experimental basis].
    Kuwert E
    Med Monatsschr; 1973 Oct; 27(10):438-47. PubMed ID: 4777786
    [No Abstract]   [Full Text] [Related]  

  • 50. [Antibody determination following influenza vaccination].
    Wegmann A
    Ther Umsch; 1972 Dec; 29(12):747-9. PubMed ID: 4639117
    [No Abstract]   [Full Text] [Related]  

  • 51. [Analysis of hemagglutination inhibition antibody level in patients with influenza A H1N1].
    Shen HH; Hou J; Zhao M; Xu J; Bai BK; Zhao J; Hu Y; Mao PY; Li BA; Mao YL
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2012 Aug; 26(4):270-2. PubMed ID: 23189841
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The response to vaccination against influenza A(H1N1) 2009, seasonal influenza and Streptococcus pneumoniae in adult outpatients with ongoing treatment for cancer with and without rituximab.
    Berglund A; Willén L; Grödeberg L; Skattum L; Hagberg H; Pauksens K
    Acta Oncol; 2014 Sep; 53(9):1212-20. PubMed ID: 24865118
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Data on safety and epidemiological efficiency of antiinfluenza vaccine studied on pre-school children.
    Smorodintsev AA; Mikutskaya BA; Alexandrova GI; Pleshanova RA
    J Hyg Epidemiol Microbiol Immunol; 1967; 11(3):265-77. PubMed ID: 5629946
    [No Abstract]   [Full Text] [Related]  

  • 54. [Comparative evaluation of influenza antibody titers in enzyme immunoassays and other serologic reactions following preventive vaccination and in influenza patients].
    Schmidt J; Adamczyk B; Gruhn I; Oehring H; Süss J; Vogt KH; Brunnemann H; Michaelis I; Schmidt S; Kittlick M
    Z Gesamte Hyg; 1984 Aug; 30(8):436-41. PubMed ID: 6385499
    [No Abstract]   [Full Text] [Related]  

  • 55. Haemagglutination-inhibiting antibody response to and efficacy of inactivated Hong Kong influenza vaccine.
    Sonoguchi T
    Bull World Health Organ; 1969; 41(3):517-23. PubMed ID: 5309466
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Evaluation of the effectiveness of massive vaccination against influenza].
    Slepushkin AN; Bobyleva TK; Russina AE; Vitkina BS; Ellengorn NS
    Zh Mikrobiol Epidemiol Immunobiol; 1966 Aug; 43(8):52-9. PubMed ID: 4240248
    [No Abstract]   [Full Text] [Related]  

  • 57. Adjuvanted or whole-virion vaccine for 2009 influenza A (H1N1).
    Barrett PN; Ehrlich HJ
    Lancet Infect Dis; 2011 Jul; 11(7):496-7; author reply 497-8. PubMed ID: 21700237
    [No Abstract]   [Full Text] [Related]  

  • 58. Vitamin E, vitamin A, and zinc status are not related to serologic response to influenza vaccine in older adults: an observational prospective cohort study.
    Sundaram ME; Meydani SN; Vandermause M; Shay DK; Coleman LA
    Nutr Res; 2014 Feb; 34(2):149-54. PubMed ID: 24461316
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Development of antibodies to neuraminidase of A2-Hong Kong and A2-Taiwan influenza viruses after administration of different Hong Kong vaccines and after natural infection in humans.
    Závadová H
    Acta Virol; 1973 Jul; 17(4):287-92. PubMed ID: 4148207
    [No Abstract]   [Full Text] [Related]  

  • 60. Cigarette smoking and epidemic influenza.
    Finklea JF; Sandifer SH; Smith DD
    Am J Epidemiol; 1969 Nov; 90(5):390-9. PubMed ID: 5356947
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.